Biontech Covid 19 Vaccine
- All
- News
-
"Fill And Finish": Pfizer BioNTech To Produce COVID-19 Vaccines In South Africa
Covid vaccine makers BioNTech and Pfizer said Wednesday they would produce their jab in South Africa from 2022, a first for the continent that could see much-needed immunisation drives pick up speed.
-
Pfizer Shot 97% Effective Against Symptomatic Covid: Study
Pfizer/BioNTech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies.
-
UK Bets On Millions Of Pfizer-BioNTech Vaccine Doses This Year: Minister
Britain has used an emergency approval process to jump ahead of the EU and US in rollout plans of the vaccine
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
-
Pfizer Soars 19% To All-Time High After Parent Company's Successful Vaccine Trials
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.
-
Germany Approves First Trial of COVID-19 Vaccine Candidate
Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country's regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.
-
"Fill And Finish": Pfizer BioNTech To Produce COVID-19 Vaccines In South Africa
Covid vaccine makers BioNTech and Pfizer said Wednesday they would produce their jab in South Africa from 2022, a first for the continent that could see much-needed immunisation drives pick up speed.
-
Pfizer Shot 97% Effective Against Symptomatic Covid: Study
Pfizer/BioNTech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies.
-
UK Bets On Millions Of Pfizer-BioNTech Vaccine Doses This Year: Minister
Britain has used an emergency approval process to jump ahead of the EU and US in rollout plans of the vaccine
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
-
Pfizer Soars 19% To All-Time High After Parent Company's Successful Vaccine Trials
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.
-
Germany Approves First Trial of COVID-19 Vaccine Candidate
Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country's regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.
